DANDRITE (Danish Research Institute of Translational Neuroscience) is the Danish node of the Nordic EMBL Partnership for Molecular Medicine.
The main focus of DANDRITE’s research is on molecular and translational neuroscience. Groups at DANDRITE encompass ambitious research programs that include:
DANDRITE was based on an initiative by the Lundbeck Foundation to establish a Danish node of the Nordic EMBL Partnership with a focus on neuroscience.
The center was formally inaugurated on 5 March 2013, joining the Finnish Institute for Molecular Medicine (FIMM), Molecular Infection Medicine Sweden (MIMS), and the Norwegian Centre for Molecular Medicine (NCMM) as the fourth member of the Nordic EMBL Partnership for Molecular Medicine. DANDRITE is currently in its first phase, having been approved by the Board of the Lundbeck Foundation and Aarhus University to operate for a second five-year period starting March 2018.
DANDRITE follows the operational model and core principles of the EMBL merged with the governance model of Aarhus University. It is hosted by two faculties; the Faculty of Science and Technology (Department of Molecular Biology), and the Faculty of Health (Department of Biomedicine). The center encompasses a dynamic community of over 120 researchers representing more than 20 different nationalities and connecting DANDRITE to leading neuroscience centers all over the world.
The appointment of five Group Leaders introducing original, new research topics and models of circuit neuroscience in Danish and international research, alongside three core Group Leaders that represent broad foundations of molecular and translational neuroscience, means that DANDRITE is very well equipped for cutting-edge neuroscience and fruitful synergies.